Our systems have detected that you are using a computer with an IP address located in the USA.
If you are currently not located in the USA, please click “Continue” in order to access our Website.

Local restrictions - provision of cross-border services

Swissquote Bank Ltd (“Swissquote”) is a bank licensed in Switzerland under the supervision of the Swiss Financial Market Supervisory Authority (FINMA). Swissquote is not authorized as a bank or broker by any US authority (such as the CFTC or SEC) neither is it authorized to disseminate offering and solicitation materials for offshore sales of securities and investment services, to make financial promotion or conduct investment or banking activity in the USA whatsoever.

This website may however contain information about services and products that may be considered by US authorities as an invitation or inducement to engage in investment activity having an effect in the USA.

By clicking “Continue”, you confirm that you have read and understood this legal information and that you access the website on your own initiative and without any solicitation from Swissquote.

Research Market strategy
by Swissquote Analysts
US equities extended losses on Wednesday, as investors got even more hints pointing to no stimulus before the presidential election scheduled for November. US Treasury Secretary Steven Mnuchin said that a deal between Republicans and ...
Roche Holding AG said Thursday morning that sales in the period from January to September fell on year, but it backed its outlook for 2020. Sales at the Swiss pharmaceutical major were 43.98 billion Swiss francs ($48.15 billion) for the period, down from CHF46.07 billion in the same period last...
Citigroup Inc. said Tuesday that its third-quarter profit slumped 34% and the bank set aside billions of dollars to cover potential losses in the coronavirus recession. Citigroup posted a profit of $3.23 billion, or $1.40 a share, down from $4.91 billion, or $2.07 a share, one year ago. Analysts...
AstraZeneca PLC said that it has received $486 million from the U.S. government to support the development and supply of its long-acting antibody combination AZD7442 for the prevention of Covid-19. The pharmaceutical giant said AZD7442 will advance into Phase 3 clinical trials with more than 6...
US equities extended gains on Monday, driven by tech stocks and persisting hopes that the Congress would approve a stimulus package.Apple and Amazon were among the best performers. The former surged ahead of the big event due later to...
After the best weekly performance in more than two months, Wall Street maintains the bullish stance even though the hopes for another stimulus before the election faded on Sunday. At the time of writing, the S&P 500 and Dow Jones ...